Latest News & Updates

Breaking News

  • 19 minutes ago

  • Simantini Singh Deo

Achieve Life Sciences Strengthens Leadership Team With Two Senior Appointments As Cytisinicline Moves Closer To U.S. Commercial Launch
Breaking News
Altimmune Starts Global Phase 3 PERFORMA Trial To Evaluate Pemvidutide For MASH After Promising Mid-Stage Results

Simantini Singh Deo

Other trending news you may like to read

Achieve Life Sciences Strengthens Leadership Team With Two Senior Appointments As Cytisinicline Moves Closer To U.S. Commercial Launch

Achieve Life Sciences appoints Ronald Dadino as SVP of CMC/Supply Chain and Gloria Cosgrove as SVP of Quality as cytisinicline nears U.S. launch.

Simantini Singh Deo

Pharma Now

Altimmune Starts Global Phase 3 PERFORMA Trial To Evaluate Pemvidutide For MASH After Promising Mid-Stage Results

Altimmune starts its global Phase 3 PERFORMA trial evaluating pemvidutide for MASH liver disease, following promising Phase 2b clinical results.

Simantini Singh Deo

Pharma Now

Novo Nordisk's Experimental Heart Drug Misses Late-Stage Trial Goal, Raising Pressure To Diversify Beyond Obesity

Novo Nordisk's ziltivekimab misses its Phase III cardiovascular endpoint, intensifying pressure to diversify beyond obesity.

Simantini Singh Deo

Pharma Now

AstraZeneca And Bristol Myers Squibb Reportedly Held Early Merger Talks For Potential $400 Billion Pharma Giant

AstraZeneca and Bristol Myers Squibb reportedly held preliminary merger talks for a combined company worth almost $400 billion.

Simantini Singh Deo

Pharma Now